The INK4a/ARF network in tumour suppression (original) (raw)

• Weinberg, R. A. The retinoblastoma gene and cell cycle control. Cell 81, 323–330 (1995).
  Article CAS Google Scholar
• Dyson, N. The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245–2262 (1998).
  Article CAS Google Scholar
• Serrano, M., Hannon, G. J. & Beach, D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704–707 (1993).
  Article CAS Google Scholar
• Sherr, C. J. Cancer cell cycles. Science 274, 1672–1677 (1996).
  Article CAS Google Scholar
• Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell 88, 323–331 (1997).
  Article CAS Google Scholar
• Giaccia, A. J. & Kastan, M. B. The complexity of p53 modulation: emerging patterns from diverging signals. Genes Dev. 12, 2973–2983 (1998).
  Article CAS Google Scholar
• Sionov, R. V. & Haupt, Y. The cellular response to p53: the decision between life and death. Oncogene 18, 6145–6157 (1999).
  Article CAS Google Scholar
• Bates, S. & Vousden, K. H. Mechanisms of p53-mediated apoptosis. Cell. Mol. Life Sci. 55, 28–37 (1999).
  Article CAS Google Scholar
• Juven-Gershon, T. & Oren, M. Mdm2: the ups and downs. Mol. Med. 5, 71–83 (1999).
  Article CAS Google Scholar
• Zhang, Y. & Xiong, Y. Control of p53 ubiquitination and nuclear export by MDM2 and ARF. Cell Growth Differ. 12, 175–186 (2001).
  CAS PubMed Google Scholar
• Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J. & Bar-Sagi, D. Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell. Biol. 1, 20–26 (1999).
  Article CAS Google Scholar
• Honda, R. & Yasuda, H. Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18, 22–27 (1999).
  Article CAS Google Scholar
• Llanos, S., Clark, P. A., Rowe, J. & Peters, G. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nature Cell Biol. 3, 445–452 (2001).
  Article CAS Google Scholar
• Quelle, D. E., Zindy, F., Ashmun, R. A. & Sherr, C. J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993–1000 (1995).
  Article CAS Google Scholar
• Kamb, A. et al. A cell cycle regulator involved in genesis of many tumor types. Science 264, 436–440 (1994).
  Article CAS Google Scholar
• Ruas, M. & Peters, G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochem. Biophys. Acta Rev. Cancer 1378, F115–F177 (1998).
  Article CAS Google Scholar
• Nevins, J. R. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9, 585–593 (1998).
  CAS PubMed Google Scholar
• Harbour, J. W. & Dean, D. C. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14, 2393–2409 (2000).
  Article CAS Google Scholar
• Roussel, M. F. The INK4 family of cell cycle inhibitors in cancer. Oncogene 18, 5311–5317 (1999).
  Article CAS Google Scholar
• Lukas, J., Petersen, B. O., Holm, K., Bartek, J. & Helin, K. Deregulated expression of E2F family members induces S-phase entry and overcomes p16_INK4a_-mediated growth suppression. Mol. Cell. Biol. 16, 1047–1057 (1996).
  Article CAS Google Scholar
• DeGregori, J., Leone, G., Miron, A., Jakoi, L. & Nevins, J. R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl Acad. Sci. USA 94, 7245–7250 (1997).
  Article CAS Google Scholar
• Muller H. et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15, 267–285 (2001).
  Article CAS Google Scholar
• Humbert, P. O. et al. E2f3 is critical for normal cellular proliferation. Genes Dev. 14, 690–703 (2000).Disruption of mouse E2f3 , but not E2f1 , reduces transcription of E2f-responsive genes and retards entry into S phase.
  CAS PubMed PubMed Central Google Scholar
• Ziebold, U., Reza, T., Caron, A. & Lees, J. A. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev. 15, 386–391 (2001).
  Article CAS Google Scholar
• Lissy, N. A., Davis, P. K., Irwin, M., Kaelin, W. G. & Dowdy, S. F. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 407, 642–645 (2000).
  Article CAS Google Scholar
• Irwin, M. et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407, 645–648 (2000).
  Article CAS Google Scholar
• Yamasaki, L. et al. Loss of E2F-1 reduces tumorigenesis and extends lifespan of Rb1+/− mice. Nature Genet. 18, 360–364 (1998).
  Article CAS Google Scholar
• Pan, H. et al. Key roles for E2F1 in signaling p53-dependent apoptosis and cell division. Mol. Cell 2, 283–292 (1998).
  Article CAS Google Scholar
• Tsai, K. et al. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell 2, 293–304 (1998).
  Article CAS Google Scholar
• Lipinski, M. M. & Jacks, T. The retinoblastoma gene family in differentiation and development. Oncogene 18, 7873–7882 (1999).
  Article CAS Google Scholar
• Lukas, J. et al. Rb-dependent cell cycle inhibition by p16CDKN2A tumor suppressor. Nature 375, 503–506 (1995).
  Article CAS Google Scholar
• Koh, J., Enders, G. H., Dynlacht, B. D. & Harlow, E. Tumour-derived p16 alleles encoding proteins defective in cell cycle inhibition. Nature 375, 506–510 (1995).
  Article CAS Google Scholar
• Medema, R. H., Herrera, R. E., Lam, F. & Weinberg, R. A. Growth suppression by p16Ink4a requires functional retinoblastoma protein. Proc. Natl Acad. Sci. USA 92, 6289–6293 (1995).
  Article CAS Google Scholar
• Sherr, C. J. & Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501–1512 (1999).
  Article CAS Google Scholar
• Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A. & Berns, A. Loss of Cdkn2a (p16INK4a) confers susceptibility to metastatic melanoma in mice. Nature 413, 83–86 (2001).
  Article CAS Google Scholar
• Sharpless, N. E. et al. Loss of p16INK4a with retention of p19ARF predisposes to tumourigenesis in mice. Nature 413, 86–91 (2001).Specific disruption of Ink4a by point mutation (Ref. 35 ) or by deletion of exon 1 (Ref. 36 ), each with retention of Arf , enables definition of the role of p16 Ink4a in the mouse. Although many features initially attributed to p16 Ink4a instead reflect Arf function, Ink4a does function as a tumour-suppressor gene in the mouse.
  Article CAS Google Scholar
• Latres, E. et al. Limited overlapping roles of p15INK4b and p18INK4c cell cycle inhibitors in proliferation and tumorigenesis. EMBO J. 19, 3496–3506 (2000).
  Article CAS Google Scholar
• Herman, J. G., Jen, J., Merlo, A. & Baylin, S. B. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4b. Cancer Res. 56, 722–727 (1996).
  CAS PubMed Google Scholar
• Zindy, F. et al. Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18Ink4c and p19Ink4d. Mol. Cell. Biol. 21, 3244–3255 (2001).
  Article CAS Google Scholar
• Zindy, F. et al. Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases. Proc. Natl Acad. Sci. USA 96, 13462–13467 (1999).
  Article CAS Google Scholar
• Franklin, D. S., Godfrey, V. L., O'Brien, D. A., Deng, C. & Xiong, Y. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol. Cell. Biol. 20, 6147–6158 (2000).
  Article CAS Google Scholar
• Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27–37 (1996).
  Article CAS Google Scholar
• Kamijo, T. et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649–659 (1997).
  Article CAS Google Scholar
• Zhang, S., Ramsay, E. S. & Mock, B. A. Cdkn2a, the cyclin-dependent kinase inhibitor gene encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. Proc. Natl Acad. Sci. USA 95, 2429–2434 (1998).
  Article CAS Google Scholar
• Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J. & Cleveland, J. L. Disruption of the ARF–Mdm2–p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 13, 2658–2669 (1999).
  Article CAS Google Scholar
• Jacobs, J. J. L. et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13, 2678–2690 (1999).
  Article CAS Google Scholar
• Schmitt, C. A., McCurrach, M. E., De Stanchina, E. & Lowe, S. W. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13, 2670–2677 (1999).
  Article CAS Google Scholar
• Carnero, A., Hudson, J. D., Price, C. M. & Beach, D. H. p16INK4a and p19ARF act in overlapping pathways in cellular immortalization. Nature Cell Biol. 2, 148–155 (2000).
  Article CAS Google Scholar
• Chin, L. et al. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev. 11, 2822–2834 (1997).
  Article CAS Google Scholar
• Sherr, C. J. & DePinho, R. A. Cellular senescence: mitotic clock or culture shock. Cell 102, 407–410 (2000).
  Article CAS Google Scholar
• Wright, W. E. & Shay, J. W. Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr. Opin. Genet. Dev. 11, 98–103 (2001).
  Article CAS Google Scholar
• Sage, J. et al. Targeted disruption of the three Rb-related genes leads to loss of G1 control and immortalization. Genes Dev. 14, 3037–3050 (2000).
  Article CAS Google Scholar
• Dannenberg, J.-H., van Rossum, A., Schuijff, L. & te Riele, H. Ablation of the retinoblastoma protein gene family deregulates G1 control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev. 14, 3051–3064 (2000).
  Article CAS Google Scholar
• Peeper, D. S., Dannenberg, J.-H., Douma, S., te Riele, H. & Bernards, R. Escape from premature senescence is not sufficient for oncogenic transformation by Ras. Nature Cell Biol. 3, 198–203 (2001).References 53 and 54 show that whereas MEFs lacking Rb undergo senescence in culture, those lacking several Rb-family members seem to be immortal. Intriguingly, cells lacking Rb, p107 and p130 are resistant to growth arrest by p19 Arf.
  Article CAS Google Scholar
• Randle, D. H., Zindy, F., Sherr, C. J. & Roussel, M. F. Differential effects of p19Arf and p16Ink4a loss on senescence of murine bone marrow-derived preB cells and macrophages. Proc Natl Acad Sci USA, 98, 9654–9659 (2001).Like MEFs, mouse bone-marrow-derived pre-B cells that lack Arf are immortal, whereas bone-marrow-derived macrophages must also silence the Ink4a gene to become established as continuously growing cell lines.
  Article CAS Google Scholar
• Kiyono, T. et al. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84–88 (1998).
  Article CAS Google Scholar
• Brenner, A. J., Stampfer, M. R. & Aldaz, C. M. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene 17, 199–205 (1998).
  Article CAS Google Scholar
• Ramirez, R. D. et al. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15, 398–403 (2001).Growing primary human keratinocytes and mammary epithelial cells over feeder layers in defined medium can prevent induction of p16 Ink4a and enable their immortalization by introducing the telomerase catalytic subunit.
  Article CAS Google Scholar
• Zindy, F. et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424–2433 (1998).
  Article CAS Google Scholar
• De Stanchina, E. et al. E1A signaling to p53 involves the p19ARF tumor suppressor. Genes Dev. 12, 2434–2442 (1998).
  Article CAS Google Scholar
• Palmero, I., Pantoja, C. & Serrano, M. p19ARF links the tumor suppressor p53 to ras. Nature 395, 125–126 (1998).
  Article CAS Google Scholar
• Radfar, A., Unnikrishnan, I., Lee, H.-W., DePinho, R. A. & Rosenberg, N. p19Arf induces p53-dependent apoptosis during Abelson virus-mediated pre-B cell transformation. Proc. Natl Acad. Sci. USA 95, 13194–13199 (1998).
  Article CAS Google Scholar
• Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., and Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602 (1997).
  Article CAS Google Scholar
• Ries, S. et al. Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell 103, 321–330 (2000).Although Ras triggers Arf induction and thereby antagonizes Mdm2, Ras-dependent signalling through an Arf-independent pathway can lead to Mdm2 induction. In the absence of Arf , the latter pathway should dominate, making cells resistant to p53 induction following DNA damage.
  Article CAS Google Scholar
• Bates, S. et al. p14ARF links the tumour suppressors RB and p53. Nature 395, 124–125 (1998).
  Article CAS Google Scholar
• Leone, G. et al. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol. Cell 8, 105–113 (2001).
  Article CAS Google Scholar
• Khan, S. H., Moritsugu, J. & Wahl, G. M. Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion. Proc. Natl Acad. Sci. USA 97, 3266–3271 (2000).DNA damage activates p53 through both Arf -independent and Arf -dependent signalling pathways, so Arf loss affects the durability of the DNA-damage response.
  Article CAS Google Scholar
• Kastan, M. B. & Lim, D. The many substrates and functions of ATM. Nature Rev. Mol. Cell Biol. 1, 179–186 (2000).
  Article CAS Google Scholar
• Maya, R. et al. ATM-dependent phosphorylation of Mdm2 on serine 395: role of p53 activation by DNA damage. Genes Dev. 15, 1067–1077 (2001).
  Article CAS Google Scholar
• Lin, W.-C., Lin, F.-T. & Nevins, J. R. Selective induction of E2F1 in response to DNA damage mediated by ATM-dependent phosphorylation. Genes Dev. 15, 1833–1844 (2001).The Atm kinase phosphorylates E2f1, enhancing its activity. This indicates a novel mechanism by which ATM might induce p53.
  CAS PubMed PubMed Central Google Scholar
• Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A. & van Lohuizen, M. The oncogene and polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164–168 (1999).
  Article CAS Google Scholar
• Maestro, R. et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev. 13, 2207–2217 (1999).
  Article CAS Google Scholar
• Jacobs, J. J. L. et al. Senescence bypass screen identified TBX2, which represses cdkn2a (p19ARF) and is amplified in a subset of human breast cancers. Nature Genet. 26, 291–299 (2000).
  Article CAS Google Scholar
• Pantoja, C. & Serrano, M. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 18, 4974–4982 (1999).
  Article CAS Google Scholar
• Kamijo, T. et al. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl Acad. Sci. USA 95, 8292–8297 (1998).
  Article CAS Google Scholar
• Stott, F. et al. The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17, 5001–5014 (1998).
  Article CAS Google Scholar
• Weber, J. D. et al. p53-independent functions of the p19ARF tumor suppressor. Genes Dev. 14, 2358–2365 (2000).Mice lacking Arf, Mdm2 and p53 show a broader spectrum of tumours than those lacking Mdm2 and p53 . Introduction of p19 Arf into primary MEFs that lack Arf, Mdm2 and p53 induces G1 arrest, albeit slowly. Arf must interact with proteins other than Mdm2.
  Article CAS Google Scholar